Black Diamond Therapeutics, Inc.

BDTX · Biological Products, (No Diagnostic Substances)

Chemicals and Allied Products boards →

Directors

Avg Age

5.1

Avg Tenure (yrs)

67%

Independent

Independent Non-independent Near rotation

Board Members

Mark A. Velleca, M.D., Ph.D. Chair

Erika Jones Director

...and 7 more directors

The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.

Get Seats Opening

Source: SEC DEF 14A proxy statement filed 2026-04-29. Data extracted and structured by FindABoardSeat.